Javascript must be enabled to continue!
Quantification and Three-Dimensional Imaging of the Insulitis-Induced Destruction of β-Cells in Murine Type 1 Diabetes
View through CrossRef
OBJECTIVE
The aim of this study was to refine the information regarding the quantitative and spatial dynamics of infiltrating lymphocytes and remaining β-cell volume during the progression of type 1 diabetes in the nonobese diabetic (NOD) mouse model of the disease.
RESEARCH DESIGN AND METHODS
Using an ex vivo technique, optical projection tomography (OPT), we quantified and assessed the three-dimensional spatial development and progression of insulitis and β-cell destruction in pancreata from diabetes-prone NOD and non–diabetes-prone congenic NOD.H-2b mice between 3 and 16 weeks of age.
RESULTS
Together with results showing the spatial dynamics of the insulitis process, we provide data of β-cell volume distributions down to the level of the individual islets and throughout the pancreas during the development and progression of type 1 diabetes. Our data provide evidence for a compensatory growth potential of the larger insulin+ islets during the later stages of the disease around the time point for development of clinical diabetes. This is in contrast to smaller islets, which appear less resistant to the autoimmune attack. We also provide new information on the spatial dynamics of the insulitis process itself, including its apparently random distribution at onset, the local variations during its further development, and the formation of structures resembling tertiary lymphoid organs at later phases of insulitis progression.
CONCLUSIONS
Our data provide a powerful tool for phenotypic analysis of genetic and environmental effects on type 1 diabetes etiology as well as for evaluating the potential effect of therapeutic regimes.
American Diabetes Association
Title: Quantification and Three-Dimensional Imaging of the Insulitis-Induced Destruction of β-Cells in Murine Type 1 Diabetes
Description:
OBJECTIVE
The aim of this study was to refine the information regarding the quantitative and spatial dynamics of infiltrating lymphocytes and remaining β-cell volume during the progression of type 1 diabetes in the nonobese diabetic (NOD) mouse model of the disease.
RESEARCH DESIGN AND METHODS
Using an ex vivo technique, optical projection tomography (OPT), we quantified and assessed the three-dimensional spatial development and progression of insulitis and β-cell destruction in pancreata from diabetes-prone NOD and non–diabetes-prone congenic NOD.
H-2b mice between 3 and 16 weeks of age.
RESULTS
Together with results showing the spatial dynamics of the insulitis process, we provide data of β-cell volume distributions down to the level of the individual islets and throughout the pancreas during the development and progression of type 1 diabetes.
Our data provide evidence for a compensatory growth potential of the larger insulin+ islets during the later stages of the disease around the time point for development of clinical diabetes.
This is in contrast to smaller islets, which appear less resistant to the autoimmune attack.
We also provide new information on the spatial dynamics of the insulitis process itself, including its apparently random distribution at onset, the local variations during its further development, and the formation of structures resembling tertiary lymphoid organs at later phases of insulitis progression.
CONCLUSIONS
Our data provide a powerful tool for phenotypic analysis of genetic and environmental effects on type 1 diabetes etiology as well as for evaluating the potential effect of therapeutic regimes.
Related Results
Detecting Insulitis in Type 1 Diabetes with Ultrasound Phase-change Contrast Agents
Detecting Insulitis in Type 1 Diabetes with Ultrasound Phase-change Contrast Agents
Abstract
Type 1 diabetes (T1D) results from immune infiltration and destruction of insulin-producing β-cells within the pancreatic islets of Langerhans (insulitis),...
Diabetes Mellitus: Life Style, Obesity and Insulin Resistance
Diabetes Mellitus: Life Style, Obesity and Insulin Resistance
In millennia, 40 million people were died with non-communicable diseases and diabetes is one of them. In diabetes, insulin secretions are not produced properly or resist to body an...
Abstract 1507: Aberrant oncolytic human adenovirus late mRNA translation causes failure of viral progeny production in murine cancer
Abstract 1507: Aberrant oncolytic human adenovirus late mRNA translation causes failure of viral progeny production in murine cancer
Abstract
Introduction. Oncolytic viruses have therapeutic potential in cancer by selectively replicating within malignant cells, causing death. Adenovirus type 5(Ad5...
Undiagnosed Diabetes in Acute Coronary Syndrome: A Silent Threat in Pakistan
Undiagnosed Diabetes in Acute Coronary Syndrome: A Silent Threat in Pakistan
Diabetes mellitus (DM) has emerged as one of the most pressing public health challenges globally, and Pakistan stands among the countries most severely affected. With rising urbani...
A Multi-Polygenic Risk Score Approach Incorporating Physical Activity Genotypes for Predicting Type 2 Diabetes and Associated Comorbidities: A FinnGen Study
A Multi-Polygenic Risk Score Approach Incorporating Physical Activity Genotypes for Predicting Type 2 Diabetes and Associated Comorbidities: A FinnGen Study
ABSTRACT
Aims/hypothesis
Genetic prediction of type 2 diabetes risk has proven difficult using current methods. Recent studies ...
Complex Collision Tumors: A Systematic Review
Complex Collision Tumors: A Systematic Review
Abstract
Introduction: A collision tumor consists of two distinct neoplastic components located within the same organ, separated by stromal tissue, without histological intermixing...
1328-P: COVID Associated Insulitis in Type 1 Diabetes
1328-P: COVID Associated Insulitis in Type 1 Diabetes
Recent reports suggest a potential relationship between COVID-and onset of diabetes (DM) . We present the case of a 35 yr old female with type 1 DM (T1DM) who following COVID-pneum...
7
th
International Symposium on Enabling Technologies for Life Sciences (ETP)
7
th
International Symposium on Enabling Technologies for Life Sciences (ETP)
The seventh in the series of ETP Symposia (see
Rapid Communications in Mass Spectrometry
2012,
26
, ...

